Salivary adjunct tests to determine the need for biopsy for early detection of oral
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
A living systematic review in JADA provides updated evidence on salivary adjunct tests for early oral squamous cell carcinoma (OSCC) and potentially malignant disorders; owners and specialists considering biopsy decisions now have a higher-grade evidence base to justify or withhold scalpel biopsy and reduce unnecessary procedures.
Key points
- Review title explicitly references Version 2026 1.0 and is designated a 'living systematic review,' indicating ongoing updates rather than a one-time publication.
- Authors include representatives from the ADA Science & Research Institute and NIH/NCI, signaling broad stakeholder input.
- Focus is on salivary biomarkers as triage tools before biopsy—directly relevant to oral pathology workflow and malpractice exposure for missed or over-performed biopsies.
- Published online 28 September 2026 in JADA, the highest-circulation, peer-reviewed dental journal in the U.S.
Who should care
Read the original on Journal of the American Dental Association (JADA)
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Dental manager charged with a dozen-plus felonies
- ·Regulatory
Suleman Nasimi, dentist from Hicksville practicing in Queens, charged with stealing more than $300,000 from Medicaid
- ·Regulatory
Dentist from Hicksville charged with stealing $300K from Medicaid
- ·Regulatory
As Medicaid Budgets Tighten, What Happens to Adult Dental Benefits?